Experimental Design for Omics Research: A Practical Guide for Biologists and Bioinformaticians
Why Experimental designs matter more than Bioinformatics?
The 80/20 rule of Omics: If you’re a biologist, you have probably heard for years that bioinformatics is where the real bottleneck is. If you’re a bioinformatician, you’ve probably spent those same years silently cursing while trying to polish data that never should have been generated in the first place.
Here’s the thing nobody says out loud: the most important part of an omics project happens at the bench, way before a single read hits your hard drive.
I have watched six-figure sequencing runs go down the drain because of a five-minute decision about how to pool samples. And I’ve seen small, scrappy studies land in good journals simply because the person running them thought carefully about how to set things up from day one. The difference wasn't the algorithm. It was the planning.
This is the first part of a practical guide I’m putting together on experimental design. And I want to start here because if you get this wrong, nothing else matters.
The Hard Truth About Data Rescue
Bioinformaticians are clever people. We have built tools that can adjust for batch effects, fill in missing values, and normalize data that looks like a mess. We can even map reads that have 10% mismatches effortlessly.
But let’s be real for a second. Bioinformatics can fix technical glitches. It cannot fix lack of biological intelligence.
If your controls and treated samples were processed differently, if your animals weren’t randomized, or if your extraction kit introduced a bias that correlates perfectly with your groups of interest; no normalization method, no fancy R package, and no machine learning model is going to save you.
You can run ComBat to adjust for batch effects, sure. But what you’re really doing is applying statistical band-aids that come with their own assumptions. And those assumptions often end up weakening your findings more than you would like to admit.
What Poor Design Actually Costs You?
Imagine two researchers discussing why a study failed. One blames the laboratory work, while the other blames the data analysis. Yet the real reason is often much simpler: the experiment was not designed properly in the first place.
You identify hundreds of genes that appear to be differentially expressed and publish the results. Later, another research group tries to validate those genes using qPCR but cannot reproduce your findings. The reason is not that the analysis was wrong, it is that the differences were caused by factors such as age, diet, medication, or other uncontrolled variables rather than the disease itself. As a result, months of research and valuable funding are spent investigating false leads.
Imagine your treatment is effective, but you only include two samples per group. Since every individual is naturally different, this variation masks the true effect. The results appear insignificant, and you end up discarding a treatment that could have been promising.
A well-designed dataset can be reused by researchers for many years, leading to new discoveries beyond the original study. In contrast, a poorly designed dataset is often ignored because the results are unreliable. Instead of becoming a valuable scientific resource, it simply remains stored in a database without being used.
Three Simple Rules Every Omics Researcher Should Remember
We will explore each of these topics in detail in future blogs, but if you remember only three things from this article, make them these.
1. Always prioritize biological replicates over technical replicates
This is one of the most common mistakes in omics experiments. A technical replicate means analyzing the same sample multiple times. For example, sequencing the same RNA sample three times. This mainly tells you whether your sequencing platform and laboratory procedures are consistent.
A biological replicate, on the other hand, means collecting samples from different biological individuals. For example, three different patients, three different mice, or three independently grown cell cultures. These replicates capture the natural biological variation that exists in real life.
Why is this important?
The goal of an omics experiment is not to understand a single sample; it is to understand how a biological condition behaves across a population. If your treatment works in only one sample, it may simply be a coincidence. Testing multiple biological samples helps determine whether the observed effect is consistent and truly associated with the condition being studied.
As a general guideline, three biological replicates per group are often considered the minimum, while five to ten replicates provide much more reliable results, depending on the study design and biological variability. Sequencing the same sample many times may improve measurement precision, but it cannot replace biological replication because it provides no information about natural variation between individuals.
2. Keep your experiment consistent and avoid batch effects
Not all differences in your data come from biology. Sometimes they are introduced during sample processing.
Imagine processing all control samples on Monday and all treated samples on Friday. Even if the protocol remains the same, differences in reagent lots, instrument performance, laboratory conditions, or sample handling can introduce unwanted variation. These technical differences are known as batch effects.
The best way to prevent this is to process all samples under the same conditions whenever possible. If your experiment is too large to process in a single batch, distribute samples from each experimental group evenly across all batches. For example, each sequencing run or library preparation batch should include both control and treated samples rather than separating them into different batches.
It is also a good practice to randomize the order in which samples are processed. This ensures that any unavoidable technical variation affects all study groups equally instead of introducing systematic bias.
Always remember, preventing the batch effect is much easier than trying to remove them during data analysis.
3. Decide your sample size before you start the experiment
One of the most common questions researchers ask is:
"How many samples do I actually need?"
The answer depends on the size of the biological effect you expect to detect.
If your treatment causes a large change, fewer samples may be enough. However, if the biological difference is small, as is often the case in complex diseases, you will need more samples to detect it reliably. This is where power analysis becomes useful.
Power analysis is performed before sequencing to estimate the number of samples required for your experiment. It considers factors such as expected biological variation, effect size, and the desired confidence level. Instead of guessing how many samples to collect, power analysis helps you design an experiment that has a high probability of detecting real biological differences.
Spending a little time planning your sample size before ordering reagents or sequencing can save significant time, and money. More importantly, it reduces the risk of missing meaningful biological discoveries simply because the study included too few samples.
A Message to Fellow Bioinformaticians
As bioinformaticians, our job is not just to analyze data, it is also to make sure the data are suitable for analysis.
If a collaborator sends you samples labeled simply as "Control" and "Treatment," don't hesitate to ask questions.
Were the samples collected properly?
Were they randomized?
How many biological replicates are there?
Were all samples processed under the same conditions?
These details are just as important as the sequencing data itself. Similarly, if you find that a study has only one or two biological replicates or has obvious flaws in its experimental design, discuss these limitations with the research team. Explain why the results may not be reliable and how improving the study design can lead to more meaningful conclusions.
Most importantly, don't assume that running a sophisticated bioinformatics pipeline will fix problems in the experiment. Tools like DESeq2, GATK, or other analysis software can only analyze the data they are given, they cannot correct poor experimental design or recover information that was never captured.
As bioinformaticians, we have a responsibility not only to analyze data accurately but also to promote good scientific practices. Asking the right questions before starting the analysis can prevent misleading results and ultimately lead to more reliable and reproducible research.
The 10 Golden Rules of Good Bioinformatics Practice
Start with a biological question, not a tool.
Design the experiment before writing a pipeline.
Collect sufficient biological replicates.
Record complete metadata.
Prevent batch effects instead of correcting them.
Perform quality control at every step.
Use reproducible workflows.
Validate important findings experimentally.
Make your data FAIR.
Document everything.
Next up: I'll dig into batch effects and blocking, how to spot them, how to design around them, and how to mathematically adjust for them when you have no other choice.
Comments